No serious side effects in Merck/Newlink Ebola vaccine test

LONDON (Reuters) – The first people vaccinated with an experimental Ebola shot being developed by Merck and NewLink have had no serious side effects so far, but a few experienced mild fever, Swiss researchers said on Tuesday.

—> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *